Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 46Neoplasms 45Colorectal Neoplasms 29Prostatic Neoplasms 27Lung Neoplasms 27Pancreatic Neoplasms 18Carcinoma, Non-Small-Cell Lung 12Motor Activity 11Head and Neck Neoplasms 11Urinary Bladder Neoplasms 9Ovarian Neoplasms 9Hematologic Neoplasms 9Stomach Neoplasms 8Neoplasm Metastasis 8Anxiety Disorders 8Uterine Cervical Neoplasms 7Multiple Myeloma 6Hematopoietic and Lymphatic System Neoplasm 6Esophageal Neoplasms 6Anatomic Stage I Breast Cancer AJCC v8 6Advanced Cancer 6Triple Negative Breast Neoplasms 5Smoking Cessation 5Rectal Neoplasms 5Radiodermatitis 5Gastrointestinal Neoplasms 5Colonic Neoplasms 5Squamous Cell Carcinoma of Head and Neck 4Sarcoma 4Melanoma 4

Interventions

Tobacco Products 1Standard of Care 1Methods 1Gain of Function Mutation 1Costs and Cost Analysis 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Tobacco Smoking × Standard of Care × Clear all
NCT04691297 2025-12-19

Digitally Enhanced Smoking Cessation for High Risk Smokers

Dana-Farber Cancer Institute

Phase NA Active not recruiting
153 enrolled

Tobacco Smoking, Smoking, Smoking Cessation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡